Matthew Robison, DPM
Podiatrist · Fort Wayne, INNPI 1790760882
Payments from drug & device makers
What this record shows
It is spread thinly across 36 manufacturers, the largest accounting for just 20.7%. Reporting peaked in 2020 at $2,080 and has fallen 93.1% since, to $144 in 2025.
Across 164 payments — averaging $44.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Trilliant Surgical LLC.$2K
- Osteomed LLC$2K
- Organogenesis Inc.$819
- Smith+Nephew$581
- Nevro Corp.$446
- Boston Scientific$381
- plus $2K from 30 others
Across 2 payments — averaging $1500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Skye Orthobiologics LLC$3K
What the payments were for
- Speaking & faculty fees$3,00041%
- Food & beverage$4,25159%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Trilliant Surgical LLC. | 1 | $1,500 |
| Osteomed LLC | 1 | $1,500 |
| Organogenesis Inc. | 22 | $819 |
| Smith+Nephew | 50 | $581 |
| Nevro Corp. | 4 | $446 |
| Boston Scientific | 3 | $381 |
| Medtronic | 3 | $369 |
| Sandoz | 15 | $280 |
| Amgen(2 entities) | 15 | $202 |
| In2bones USA, LLC | 2 | $131 |
| Kowa Pharmaceuticals America, Inc. | 2 | $118 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $108 |
| Treace Medical Concepts, Inc. | 4 | $97 |
| Johnson & Johnson | 2 | $72 |
| GRT US Holding, Inc. | 4 | $61 |
| Averitas Pharma Inc. | 2 | $52 |
| Stryker | 1 | $47 |
| Orthofix Medical, Inc. | 3 | $43 |
| Triad Life Sciences Inc. | 2 | $39 |
| Integra Lifesciences Corporation | 1 | $39 |
| Paratek Pharmaceuticals, Inc. | 2 | $37 |
| Linvatec Corporation | 1 | $34 |
| Anika Therapeutics, Inc. | 1 | $32 |
| Nabriva Therapeutics, PLC | 2 | $32 |
| Tactile Systems Technology Inc | 2 | $30 |
| Arthrosurface Incorporated | 2 | $29 |
| AbbVie | 1 | $27 |
| DJO, LLC | 1 | $25 |
| Alfasigma USA, Inc. | 2 | $24 |
| Acera Surgical, Inc. | 1 | $15 |
| Osiris Therapeutics Inc. | 1 | $15 |
| Paragon 28, Inc. | 1 | $15 |
| Celularity Inc. | 1 | $14 |
| Sanara Medtech Inc. | 1 | $14 |
| Medline Industries LP | 1 | $14 |
| Dynasplint Systems Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Two Step$1,500
- EXT-Extremilock Foot$1,500
- EXT-ExtremiLock Ankle$1,500
- EXT-ExtremiFix Midsize/Large$1,500
- EXT-Encompass$1,500
- EXT-Cannulated$1,500
- Omnia$265
- INTELLIS ADAPTIVESTIM$260
- Senza$133
- Affinity$125
- Puraply Antimicrobial$124
- GENERAL VASCULAR INTERVENTION$122
- CoLag$115
- PuraPly$113
- INTELLIS$109
- Seglentis$105
- GRAFIX PL$103
How this compares
$7,251 in reported general payments places this provider in the 80th percentile of 131 podiatrist providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 17 | $12,644 |
| Gabapentin | 28 | $337 |
| Allopurinol | 43 | $272 |
| Terbinafine Hcl | 25 | $246 |
| Mupirocin | 12 | $119 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $118 |
| Doxycycline Hyclate | 18 | $117 |
| Cephalexin | 17 | $94 |
| Methylprednisolone | 13 | $90 |
| Lidocaine | 13 | $77 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $70 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $108 | $12,64417 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 131 podiatrist providers in Indiana.
Other podiatrist in Fort Wayne
- Townsen KenningtonFort Wayne$20K
- Richard HilkerFort Wayne$4K
- Andrew RaderJasper$726K
- Anthony MillerIndianapolis$292K
- Corey GrohIndianapolis$57K
- Jeffrey StevensIndianapolis$56K
- James VestileTipton$44K
- Andrew KapsalisAvon$37K
- Scott HoffmanAvon$22K
- John RachoyMunster$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.